L A Speicher

646 total citations
8 papers, 545 citations indexed

About

L A Speicher is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, L A Speicher has authored 8 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in L A Speicher's work include Microtubule and mitosis dynamics (3 papers), Cancer therapeutics and mechanisms (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). L A Speicher is often cited by papers focused on Microtubule and mitosis dynamics (3 papers), Cancer therapeutics and mechanisms (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). L A Speicher collaborates with scholars based in United States and India. L A Speicher's co-authors include Linda R. Barone, K D Tew, Kenneth D. Tew, G. R. Hudes, Robert L. Comis, Richard M. Scher, Robert L. Krigel, Perry Watts, Richard E. Greenberg and Samuel Litwin and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Biochemistry.

In The Last Decade

L A Speicher

8 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L A Speicher United States 8 298 295 182 104 88 8 545
Uri Sagman Canada 11 461 1.5× 231 0.8× 381 2.1× 40 0.4× 44 0.5× 19 905
Evangelos Bournakis Greece 15 267 0.9× 160 0.5× 272 1.5× 153 1.5× 39 0.4× 35 621
S. Curley United States 8 274 0.9× 134 0.5× 287 1.6× 50 0.5× 50 0.6× 12 606
Shinichiro Ryuge Japan 18 347 1.2× 239 0.8× 417 2.3× 137 1.3× 48 0.5× 36 738
Shinako Araki United States 10 400 1.3× 132 0.4× 335 1.8× 166 1.6× 45 0.5× 14 690
Diana Bello United States 8 135 0.5× 258 0.9× 253 1.4× 119 1.1× 33 0.4× 12 580
M Volm Germany 13 459 1.5× 126 0.4× 293 1.6× 175 1.7× 27 0.3× 42 749
K. N. Canada 11 208 0.7× 213 0.7× 286 1.6× 144 1.4× 16 0.2× 21 509
Valerie Odero‐Marah United States 10 262 0.9× 222 0.8× 334 1.8× 139 1.3× 32 0.4× 22 593

Countries citing papers authored by L A Speicher

Since Specialization
Citations

This map shows the geographic impact of L A Speicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L A Speicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L A Speicher more than expected).

Fields of papers citing papers by L A Speicher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L A Speicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L A Speicher. The network helps show where L A Speicher may publish in the future.

Co-authorship network of co-authors of L A Speicher

This figure shows the co-authorship network connecting the top 25 collaborators of L A Speicher. A scholar is included among the top collaborators of L A Speicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L A Speicher. L A Speicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Alberts, David S., L A Speicher, Mary F. Krutzsch, et al.. (1996). WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells. European Journal of Cancer. 32. S17–S20. 24 indexed citations
2.
Speicher, L A, et al.. (1994). Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.. Molecular Pharmacology. 46(5). 866–872. 31 indexed citations
3.
Speicher, L A, Linda R. Barone, G. R. Hudes, et al.. (1994). P-glycoprotein Binding and Modulation of the Multidrug-Resistant Phenotype by Estramustine. JNCI Journal of the National Cancer Institute. 86(9). 688–694. 59 indexed citations
4.
Hudes, G. R., Richard E. Greenberg, Robert L. Krigel, et al.. (1992). Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.. Journal of Clinical Oncology. 10(11). 1754–1761. 206 indexed citations
5.
Speicher, L A, Linda R. Barone, & K D Tew. (1992). Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.. PubMed. 52(16). 4433–40. 119 indexed citations
6.
Speicher, L A, et al.. (1991). Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype. British Journal of Cancer. 64(2). 267–273. 18 indexed citations
7.
Speicher, L A, et al.. (1991). Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry. 30(34). 8371–8379. 60 indexed citations
8.
Speicher, L A, et al.. (1991). The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells.. PubMed. 54(2). 268–76. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026